Solid Biosciences share price logo

Solid Biosciences

NASDAQ: SLDB

Small Cap

$7.29

-0.19

(-2.54%)

as on

Solid Biosciences Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.15
    $7.54
    downward going graph

    1.92%

    Downside

    3.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.79
    $11.45
    downward going graph

    48.01%

    Downside

    57.06%

    Upside

    downward going graph

Solid Biosciences share price movements today

Previous Close
$7.48
Open
$7.50
Volume
1.2M
Market Cap
$802.0M
Day's Low - High
$7.15 - $7.54
52 Week Low - High
$3.79 - $11.45

Solid Biosciences Historical Returns

1 Month Return
-25 %
3 Month Return
-21.53 %
1 Year Return
+ 18.54 %
3 Year Return
+ 180.38 %
5 Year Return
-81.8 %

Solid Biosciences Stock Fundamentals & Key Indicators

Check Solid Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$802.0M

EPS (TTM)

-1.91

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.92

Industry PE ratio

-8.07

PEG Ratio

-0.12196085640824005

EBITDA

-205.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-72.28%

Solid Biosciences Stock Valuation

Track how Solid Biosciences P/E has moved over time to understand its valuation trends.

Solid Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-2.83x)

December 31, 2025

Industry (-8.07x)

December 31, 2025

Today (-2.83x)

December 31, 2025

Highest (-0.53x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -2.83x

Solid Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Solid Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$802.0M-81.8%-3.920.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Solid Biosciences Stock including INR - Dollar returns

The Solid Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Solid Biosciences investment value today

Current value as on today

₹1,28,046

Returns

₹28,046

(+28.05%)

Returns from Solid Biosciences Stock

₹18,537 (+18.54%)

Dollar Impact

₹9,509 (+9.51%)

Analyst Recommendation on Solid Biosciences Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Solid Biosciences. Average target price of $18.62

Solid Biosciences Share Price Target

Get share price movements and forecasts by analysts on Solid Biosciences.

What analysts predicted

60.85%UPSIDE

Target Price

$18.62

Current Price

$7.29

Analyzed by

8 Analysts

High

$26

Target

$18.62

Low

$11

Solid Biosciences target price $18.62, a slight upside of 60.85% compared to current price of $7.29. According to 8 analysts rating.

Indian Investors' Interest in Solid Biosciences Stock

Search interest for Solid Biosciences Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Solid Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
0
0
-
-
0
-
Operating Income
-26
-27
-35
-39
-40
-41
-48
-49
-57
-57
EBITDA
-23
-23
-32
-42
-38
-39
-45
-49
-56
-54
Interest Expense
0
0
0
0
0
0
-
-
-
-
Depreciation
0
1
0
0
0
0
0
0
0
0
Income Before Tax
-24
-25
-32
-42
-39
-39
-45
-49
-56
-54
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-24
-25
-32
-42
-39
-39
-45
-49
-56
-54
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Solid Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
13
8
-
-
-
Gross Profit
0
-1
-2
-3
13
8
-2
-2
-1
Operating Income
-54
-75
-119
-86
-72
-106
-104
-129
-179
EBITDA
-54
-75
-116
-84
-69
-96
-93
-121
-172
Interest Expense
-
-
-
-
-
-
-
0
-
Depreciation
0
1
2
3
2
2
2
2
1
Income Before Tax
-53
-74
-117
-88
-72
-85
-96
-124
-174
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-52
-74
-117
-88
-72
-85
-96
-124
-174
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
0.00%
0.00%
0.00%

Solid Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-24
-25
-32
-42
-39
-39
-45
-49
-56
-54
Operating Cash Flow
-25
-21
-23
-29
-31
-37
-33
-53
-47
-52
Investing Cash Flow
-38
-5
-10
38
-27
-32
-45
47
44
-133
Financing Cash Flow
107
5
3
6
189
-1
1
5
239
48
Change in Cash
43
-21
-31
15
130
-71
-77
-1
236
-137

Solid Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-74
-117
-88
-72
-85
-96
-124
-174
Operating Cash Flow
-43
-70
-92
-56
-77
-97
-94
-100
-156
Investing Cash Flow
10
-26
24
6
-91
59
9
-16
-58
Financing Cash Flow
77
131
57
128
134
74
3
122
194
Change in Cash
44
34
-10
78
-33
36
-81
6
-20

Mutual Funds that own Solid Biosciences Stock

Check out the Mutual Funds with significant holdings in Solid Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.428752%
2604236
Fidelity Select Portfolios
1.670464%
1791160
COLUMBIA FUNDS SERIES TRUST I
1.410764%
1512696
Franklin Strategic Series
1.16948%
1253978
Fidelity Advisor Series VII
0.631908%
677565

Global Institutional Holdings in Solid Biosciences

Funds
Holdings
Peter Kolchinsky
11.23%
Joseph Edelman
11.1%
Vanguard
4.49%
iShares
3.6%
VANGUARD INDEX FUNDS
2.43%

Insights on Solid Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SLDB has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 693.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SLDB stock has moved down by -18.2%

About Solid Biosciences

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.
OrganisationSolid Biosciences
Headquarters500 Rutherford Avenue, Charlestown, MA, 02129, US
IndustryBiotechnology
CEOAlexander G. Cumbo
E-voting on sharesClick here to vote

Key Management of Solid Biosciences

Name

Title

Mr. Ian F. Smith A.C.A., C.P.A.

Executive Chair

Mr. Ilan Ganot

Co-founder, Strategic Advisor to the CEO & Director

Mr. David Tyronne Howton Jr., J.D.

COO & Secretary

Mr. Kevin Tan C.F.A.

CFO & Treasurer

Ms. Nicole Anderson

Senior Director of Investor Relations & Corporate Communications

Mr. Alexander G. Cumbo

President, CEO & Director

Dr. Gabriel Brooks M.D.

Chief Medical Officer

Ms. Annie Ganot

Co-Founder & VP of Patient Advocacy

Mr. Paul Herzich

Chief Technology Officer

Dr. Jessie Hanrahan Ph.D.

Chief Regulatory & Preclinical Operations Officer

FAQs

What is Solid Biosciences share price today?

Solid Biosciences share price today is $7.29 as on at the close of the market. Solid Biosciences share today touched a day high of $7.54 and a low of $7.15.

What is the 52 week high and 52 week low for Solid Biosciences share?

Solid Biosciences share touched a 52 week high of $11.45 on and a 52 week low of $3.79 on . Solid Biosciences stock price today i.e. is closed at $7.29,which is 36.33% down from its 52 week high and 92.35% up from its 52 week low.

What is Solid Biosciences's market capitalisation today?

Solid Biosciences market capitalisation is $0.00T as on .

How to invest in Solid Biosciences Stock (SLDB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Solid Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Solid Biosciences Shares that will get you 0.2058 shares as per Solid Biosciences share price of $7.29 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Solid Biosciences Stock (SLDB) from India?

Indian investors can start investing in Solid Biosciences (SLDB) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Solid Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Solid Biosciences share’s latest price of $7.29 as on September 26, 2026 at 8:45 am IST, you will get 1.3717 shares of Solid Biosciences. Learn more about fractional shares .

What are the returns that Solid Biosciences has given to Indian investors in the last 5 years?

Solid Biosciences stock has given -81.8% share price returns and 29.98% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?